Shares of Aurora Cannabis (TSX:ACB) rallied on Monday (September 17) after a report indicated the company was the target partner for The Coca-Cola Company (NYSE:KO) for the development of wellness beverages infused with CBD.

The report from BNN Bloomberg indicated the partnership between Aurora and the beverage giant would seek to develop “beverages that will ease inflammation, pain and cramping.”

Unnamed sources said in the report the deal was “pretty advanced down the path” and would target the wellness market.

Stocks for Aurora closed Monday’s trading session with a whopping 16.86 percent increase in value from its previous closing price. ACB finished with a price per share of C$9.98.

Coca-Cola shares on the New York Stock Exchange also rose following the report. The share price for Coca-Cola raised to $46.32, representing a 0.72 percent hike.

During after hours trading, shares of the beverage company were up 0.32 percent on top of its closing price.

The massive beverage company behind popular sodas like Coke, Sprite and Dasani water counts with a US$197 billion market cap.

According to the report, representatives from Coca-Cola also met with Aphria (TSX:APH). However, conversations with the licensed producer (LP) didn’t advance much after.

Coca-Cola confirms interest in “non-psychoactive CBD”

After speculation ran rampant on Monday, Coca-Cola issued a statement in an attempt to clarify the rumors.

“We have no interest in marijuana or cannabis. Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. The space is evolving quickly. No decisions have been made at this time.”

Beverage companies seek potential in cannabis market

If confirmed, the move by Coca-Cola would continue a trend of established beverage companies seeking or obtaining entries into the emerging cannabis space.

Most recently, rumors circled of alcohol producer Diageo (NYSE:DEO) seeking some form of partnership with one of the Canadian licensed producers.

Doug Waterson, CFO and portfolio manager with Faircourt Asset Management and manager of the Ninepoint UIT Alternative Health Fund told the Investing News Network (INN) a majority of the rally for Tilray was due to its leading position as the company set to win the partnership with Diageo.

Last year, Constellation Brands (NYSE:STZ) became the first alcohol producer to get involved with the public cannabis space directly following an investment deal into Canopy Growth (NYSE:CGC,TSX:WEED).

In August, that relationship showed its evolution as Constellation Brands re-upped in Canopy supplying the producer with a C$5 billion investment to help the company expand international opportunities.

“Over the past year, we’ve come to better understand the cannabis market, the tremendous growth opportunity it presents, and Canopy’s market-leading capabilities in this space,” Rob Sands, CEO of Constellation Brands said.

The partnership between these two is also set to develop cannabis infused beverages.

Charles Taerk, president and CEO of Faircourt Asset Management, told INN the move from Constellation brought legitimacy to the cannabis space and made him ask himself which company was next for a partnership.

“[There is a] list of companies that we feel are well positioned, have capacity and don’t have a dance partner, so it’s potential,” Taerk said.

The other alcohol company to enter the cannabis space was Molson Coors Brewing (NYSE:TAP,TSX:TPX). The company formed a joint venture with cannabis Quebec-based LP HEXO (TSX:HEXO), formerly known as The Hydropothecary Corporation.

The new entity will also seek to develop non-alcoholic beverages infused with cannabis.

Investor takeaway

The entry from another beverage company into the cannabis space would only help to improve the legitimation process the industry has embarked on this year as legalization is weeks away in Canada.

Pressure for beverage companies to diversify and find new revenue streams has also been at the centre of these moves into the cannabis space.

Don’t forget to follow us @INN_Cannabis for real-time news updates and stay tuned for cannabis stories from the MoneyShow!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less